bluebird bio BLUE reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
bluebird bio beat estimated earnings by 16.07%, reporting an EPS of $-0.94 versus an estimate of $-1.12.
Revenue was down $22.61 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 22.05% increase in the share price the next day.
Here's a look at bluebird bio's past performance:
Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
---|---|---|---|---|
EPS Estimate | -1.24 | -1.39 | -1.88 | -2.58 |
EPS Actual | -1.27 | -1.66 | -2.14 | -3.16 |
Revenue Estimate | 680K | 730K | 5.08M | 26.06M |
Revenue Actual | 1.52M | 1.95M | 1.61M | 22.68M |
To track all earnings releases for bluebird bio visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.